ALHC

SEC source: 0001628280-25-018049 · wk-form4_1744837433.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,132,899

F1 · kind: Date of Rule 10b5-1 plan adoption: 11/25/2024

SEC source: 0001628280-25-018046 · wk-form4_1744837349.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 2,003,100

F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2024

F2 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

SEC source: 0001628280-25-016334 · wk-form4_1743635108.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 415,022

F1 · kind: Date of Rule 10b5-1 plan adoption: 11/27/2024

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $18.14 to $18.84. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-015516 · wk-form4_1743208155.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,362,899

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.50 to $18.05. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-015515 · wk-form4_1743208100.xml · nonDerivative · entry 1

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,464,419

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.50 to $18.05. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-015514 · wk-form4_1743208019.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,923,186

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.50 to $18.05. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-015518 · wk-form4_1743208226.xml · nonDerivative · entry 1

Scavo Robert L. · CIK 0001975024 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 702,953

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.50 to $18.05. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-015517 · wk-form4_1743208185.xml · nonDerivative · entry 1

Kardes Hakan · CIK 0001975023 · Chief Experience Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 678,987

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.50 to $18.05. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-014386 · wk-form4_1742598755.xml · nonDerivative · entry 1

Kim Hyong · CIK 0001993255 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 509,367

F1 · kind: Date of Rule 10b5-1 plan adoption: 09/05/2024

SEC source: 0001628280-25-013961 · wk-form4_1742435517.xml · nonDerivative · entry 3

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 440,022

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.73 to $17.12. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-013961 · wk-form4_1742435517.xml · nonDerivative · entry 2

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 443,981

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.73 to $16.72. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-013968 · wk-form4_1742435788.xml · nonDerivative · entry 3

Wagner Andreas P. · CIK 0002006326 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 223,474

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.73 to $17.12. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-013968 · wk-form4_1742435788.xml · nonDerivative · entry 2

Wagner Andreas P. · CIK 0002006326 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 226,217

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.73 to $16.72. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-013966 · wk-form4_1742435697.xml · nonDerivative · entry 2

Burzacchi Sebastian · CIK 0002002259 · COO - Mgmt Services Org

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,378

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.73 to $17.12. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-013966 · wk-form4_1742435697.xml · nonDerivative · entry 1

Burzacchi Sebastian · CIK 0002002259 · COO - Mgmt Services Org

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 252,784

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.73 to $16.72. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-013957 · wk-form4_1742435411.xml · nonDerivative · entry 3

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,374,051

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.73 to $17.12. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-013957 · wk-form4_1742435411.xml · nonDerivative · entry 2

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,379,993

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.73 to $16.72. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-013954 · wk-form4_1742435370.xml · nonDerivative · entry 3

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,471,163

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.73 to $17.12. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-013954 · wk-form4_1742435370.xml · nonDerivative · entry 2

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,475,271

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.73 to $16.72. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-013952 · wk-form4_1742435319.xml · nonDerivative · entry 3

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,957,616

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.73 to $17.12. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-013952 · wk-form4_1742435319.xml · nonDerivative · entry 2

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,969,871

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.73 to $16.72. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-013965 · wk-form4_1742435668.xml · nonDerivative · entry 3

Scavo Robert L. · CIK 0001975024 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 705,817

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.73 to $17.12. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-013965 · wk-form4_1742435668.xml · nonDerivative · entry 2

Scavo Robert L. · CIK 0001975024 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 708,417

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.73 to $16.72. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-013963 · wk-form4_1742435595.xml · nonDerivative · entry 3

Kardes Hakan · CIK 0001975023 · Chief Experience Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 686,212

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.73 to $17.12. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-013963 · wk-form4_1742435595.xml · nonDerivative · entry 2

Kardes Hakan · CIK 0001975023 · Chief Experience Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 688,585

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.73 to $16.72. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-013958 · wk-form4_1742435447.xml · nonDerivative · entry 2

Kim Hyong · CIK 0001993255 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 536,101

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.73 to $17.12. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-013958 · wk-form4_1742435447.xml · nonDerivative · entry 1

Kim Hyong · CIK 0001993255 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 539,072

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.73 to $16.72. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-013961 · wk-form4_1742435517.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 451,038

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the grant of immediately vested common stock acquired on March 13, 2025 and reported on a Form 4 filed with the SEC on March 17, 2025. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.85 to $16.93. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-013968 · wk-form4_1742435788.xml · nonDerivative · entry 1

Wagner Andreas P. · CIK 0002006326 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 231,106

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the grant of immediately vested common stock acquired on March 13, 2025 and reported on a Form 4 filed with the SEC on March 17, 2025. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.85 to $16.93. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-013957 · wk-form4_1742435411.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,390,586

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the grant of immediately vested common stock acquired on March 13, 2025 and reported on a Form 4 filed with the SEC on March 17, 2025. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.85 to $16.93. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-013954 · wk-form4_1742435370.xml · nonDerivative · entry 1

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,482,595

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the grant of immediately vested common stock acquired on March 13, 2025 and reported on a Form 4 filed with the SEC on March 17, 2025. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.85 to $16.93. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-013952 · wk-form4_1742435319.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,991,717

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the grant of immediately vested common stock acquired on March 13, 2025 and reported on a Form 4 filed with the SEC on March 17, 2025. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.85 to $16.93. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-013965 · wk-form4_1742435668.xml · nonDerivative · entry 1

Scavo Robert L. · CIK 0001975024 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 713,051

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the grant of immediately vested common stock acquired on March 13, 2025 and reported on a Form 4 filed with the SEC on March 17, 2025. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.85 to $16.93. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-013963 · wk-form4_1742435595.xml · nonDerivative · entry 1

Kardes Hakan · CIK 0001975023 · Chief Experience Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 692,814

F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2024

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.98 to $17.09. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-013228 · wk-form4_1742248654.xml · nonDerivative · entry 2

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,417,700

F2 · kind: Date of Rule 10b5-1 plan adoption: 03/13/2024

F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.53 to $16.20. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0000950142-25-000765 · es250603980_4-alhc1.xml · nonDerivative · entry 1

GENERAL ATLANTIC, L.P. · CIK 0001017645 · Director · 10% owner

GENERAL ATLANTIC GENPAR, L.P. · CIK 0001467926 · Director · 10% owner

General Atlantic Partners 95, L.P. · CIK 0001606259 · Director · 10% owner

GAP COINVESTMENTS III, LLC · CIK 0001282203 · Director · 10% owner

GAP COINVESTMENTS IV, LLC · CIK 0001282372 · Director · 10% owner

GAP Coinvestments V, LLC · CIK 0001793941 · Director · 10% owner

GAPCO GMBH & CO KG · CIK 0001187388 · Director · 10% owner

GAPCO MANAGEMENT GMBH · CIK 0001187390 · Director · 10% owner

GAP Coinvestments CDA, L.P. · CIK 0001356474 · Director · 10% owner

General Atlantic (SPV) GP, LLC · CIK 0001793940 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 61,302,175

F2 · kind: Represents 18,710 restricted stock units which were granted to David C. Hodgson, who is an employee of GASC and director of the Issuer, on March 13, 2025, each restricted stock unit representing a right to receive one share of Common Stock of the Issuer, all of which will vest on the one-year anniversary of the grant date unless Mr. Hodgson ceases to serve as a member of the Board of Directors prior to such date.

F3 · kind: Represents 18,710 restricted stock units which were granted to Nicholas Robbert Vorhoff, who is an employee of GASC and director of the Issuer, on March 13, 2025, each restricted stock unit representing a right to receive one share of Common Stock of the Issuer, all of which will vest on the one-year anniversary of the grant date unless Mr. Vorhoff ceases to serve as a member of the Board of Directors prior to such date.

F1 · ownership.nature: The securities are held solely for the benefit of General Atlantic Service Company, L.P. ("GASC"), which is controlled by the Partnership Committee of GASC MGP, LLC (the "Partnership Committee"). Each of the members of the Partnership Committee disclaims ownership of the shares except to the extent that he has a pecuniary interest therein.

F2 · ownership.nature: Represents 18,710 restricted stock units which were granted to David C. Hodgson, who is an employee of GASC and director of the Issuer, on March 13, 2025, each restricted stock unit representing a right to receive one share of Common Stock of the Issuer, all of which will vest on the one-year anniversary of the grant date unless Mr. Hodgson ceases to serve as a member of the Board of Directors prior to such date.

F3 · ownership.nature: Represents 18,710 restricted stock units which were granted to Nicholas Robbert Vorhoff, who is an employee of GASC and director of the Issuer, on March 13, 2025, each restricted stock unit representing a right to receive one share of Common Stock of the Issuer, all of which will vest on the one-year anniversary of the grant date unless Mr. Vorhoff ceases to serve as a member of the Board of Directors prior to such date.

SEC source: 0001628280-25-013244 · wk-form4_1742249053.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 457,763

F1 · shares: Represents (i) 56,452 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date; and (ii) 14,337 fully vested shares of Common Stock granted in lieu of cash settlement of the annual incentive award earned by the reporting person for the 2024 fiscal year.

SEC source: 0001628280-25-013215 · wk-form4_1742248437.xml · nonDerivative · entry 1

Wagner Andreas P. · CIK 0002006326 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 235,994

F1 · shares: Represents (i) 25,806 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date; and (ii) 9,303 fully vested shares of Common Stock granted in lieu of cash settlement of the annual incentive award earned by the reporting person for the 2024 fiscal year.

SEC source: 0001628280-25-013222 · wk-form4_1742248575.xml · nonDerivative · entry 1

Burzacchi Sebastian · CIK 0002002259 · COO - Mgmt Services Org

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 257,072

F1 · shares: Represents 39,677 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

SEC source: 0000950142-25-000766 · es250603981_4-alhc2.xml · nonDerivative · entry 1

General Atlantic (ALN HLTH), L.P. · CIK 0001853603 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 61,302,175

F2 · kind: Represents 18,710 restricted stock units which were granted to David C. Hodgson, who is an employee of GASC and director of the Issuer, on March 13, 2025, each restricted stock unit representing a right to receive one share of Common Stock of the Issuer, all of which will vest on the one-year anniversary of the grant date unless Mr. Hodgson ceases to serve as a member of the Board of Directors prior to such date.

F3 · kind: Represents 18,710 restricted stock units which were granted to Nicholas Robbert Vorhoff, who is an employee of GASC and director of the Issuer, on March 13, 2025, each restricted stock unit representing a right to receive one share of Common Stock of the Issuer, all of which will vest on the one-year anniversary of the grant date unless Mr. Vorhoff ceases to serve as a member of the Board of Directors prior to such date.

F1 · ownership.nature: The securities are held solely for the benefit of General Atlantic Service Company, L.P. ("GASC"), which is controlled by the Partnership Committee of GASC MGP, LLC (the "Partnership Committee"). Each of the members of the Partnership Committee disclaims ownership of the shares except to the extent that he has a pecuniary interest therein.

F2 · ownership.nature: Represents 18,710 restricted stock units which were granted to David C. Hodgson, who is an employee of GASC and director of the Issuer, on March 13, 2025, each restricted stock unit representing a right to receive one share of Common Stock of the Issuer, all of which will vest on the one-year anniversary of the grant date unless Mr. Hodgson ceases to serve as a member of the Board of Directors prior to such date.

F3 · ownership.nature: Represents 18,710 restricted stock units which were granted to Nicholas Robbert Vorhoff, who is an employee of GASC and director of the Issuer, on March 13, 2025, each restricted stock unit representing a right to receive one share of Common Stock of the Issuer, all of which will vest on the one-year anniversary of the grant date unless Mr. Vorhoff ceases to serve as a member of the Board of Directors prior to such date.

SEC source: 0001628280-25-013240 · wk-form4_1742248892.xml · nonDerivative · entry 1

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,496,410

F1 · shares: Represents (i) 61,290 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date; and (ii) 32,258 fully vested shares of Common Stock granted as a discretionary award to the reporting person by the Board of Directors.

SEC source: 0001628280-25-013228 · wk-form4_1742248654.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,447,700

F1 · shares: Represents (i) 119,355 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date; (ii) 19,355 fully vested shares of Common Stock granted in lieu of cash settlement of the annual incentive award earned by the reporting person for the 2024 fiscal year; and (iii) 32,258 fully vested shares of Common Stock granted as a discretionary award to the reporting person by the Board of Directors.

SEC source: 0001628280-25-013253 · wk-form4_1742249537.xml · nonDerivative · entry 1

McCarthy Margaret M · CIK 0001485980 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 128,878

F1 · shares: Represents 12,258 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. The reporting person has elected to defer receipt of the underlying shares until separation of service as a director (or, if earlier, until a change of control of the Company).

SEC source: 0001628280-25-013238 · wk-form4_1742248758.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,019,252

F1 · shares: Represents (i) 274,194 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date; and (ii) 64,516 fully vested shares of Common Stock granted as a discretionary award to the reporting person by the Board of Directors.

SEC source: 0001628280-25-013250 · wk-form4_1742249419.xml · nonDerivative · entry 1

KOSECOFF JACQUELINE B · CIK 0001209524 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 290,867

F1 · shares: Represents 12,258 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date.

SEC source: 0001628280-25-013260 · wk-form4_1742249905.xml · nonDerivative · entry 1

KONOWIECKI JOSEPH S · CIK 0001209523 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,147,146

F1 · shares: Represents 12,258 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. The reporting person has elected to defer receipt of the underlying shares for three years (or, if earlier, upon separation of service or a change of control of the Company).

SEC source: 0001628280-25-013257 · wk-form4_1742249773.xml · nonDerivative · entry 1

BILNEY JODY L · CIK 0001185995 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,228

F1 · shares: Represents 15,484 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. The reporting person has elected to defer receipt of the underlying shares until separation from service (or, if earlier, until change of control of the Company).

SEC source: 0001628280-25-013255 · wk-form4_1742249641.xml · nonDerivative · entry 1

JORDEN YON · CIK 0001189397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,734

F1 · shares: Represents 12,258 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date.

SEC source: 0001628280-25-013264 · wk-form4_1742250210.xml · nonDerivative · entry 1

HODGSON DAVID C · CIK 0001193346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,426

F1 · shares: Represents 18,710 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. The reporting person has elected to defer receipt of the underlying shares until separation of service as a director (or, if earlier, until a change of control of the Company). The restricted stock units granted to the reporting person are held by him solely for the benefit of General Atlantic Service Company, L.P. The reporting person disclaims beneficial ownership of the restricted stock units and the underlying Common Stock.

SEC source: 0001628280-25-013266 · wk-form4_1742250295.xml · nonDerivative · entry 1

McClellan Mark B. · CIK 0001567006 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 357,435

F1 · shares: Represents 12,258 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date.